Archive for January, 2009

BYD AUTO (Build Your Dreams), F3DM HYBRID

Friday, January 30th, 2009

BYD AUTO F3DM HYBRID Here are BYD’s claims for it’s new Hybrid Car. Safety
Dual Mode (DM) Electric Vehicle features BYD’s new-generation Fe battery, which has high efficiency, a long cycle life and excellent safety performance.

Excellent Performance
BYD’s Dual Mode (DM) Electric Vehicle system features increased power and torque
Total output of 125kw (168hp)
The BYD F3DM performs like a car with a conventional 2.4-liter gasoline engine
It will give owners a new driving experience.

Low Cost
The F3DM consumes 16kwh of electricity per 100km (62mi)
The Dual Mode (DM) Electric Vehicle system adopts BYD’s latest-generation gasoline engine

Convenient Recharging
The F3DM can be recharged by using a normal household power outlet.

Environmentally-Friendly & Energy-Efficient
In everyday driving, most people (about 95%) will drive less than 100km (60 mi) per day
BYD’s Dual Mode (DM) Electric Vehicles can run at zero fuel consumption and zero emission levels in EV Mode.

Read the full story in our Green Auto News Page.


Wednesday, January 28th, 2009

A University of Rochester Medical Center study challenges common assumptions about the chemical bisphenol A (BPA), by showing that in some people, surprisingly high levels remain in the body even after fasting for as long as 24 hours. The finding suggests that BPA exposure may come from non-food sources, or that BPA is not rapidly metabolized, or both. The journal Environmental Health Perspectives published the research online January 28, 2009.

Controversy around BPA is mounting. In December the U.S. Food and Drug Administration agreed to reconsider the health risks of the chemical, which is used to make plastic baby bottles, water bottles and many other consumer products. Scientific studies suggest that BPA may harm the brain and prostate glands in developing fetuses and infants; adults with higher BPA levels in their urine were linked to higher risks for heart disease and diabetes, according to a study published last September in the Journal of the American Medical Association.

Read the full press release in our News Page.


Tuesday, January 27th, 2009

Most people know that too much sodium from foods can increase blood pressure.

A new study suggests that people trying to lower their blood pressure should also boost their intake of potassium, which has the opposite effect to sodium.

Researchers found that the ratio of sodium-to-potassium in subjects’ urine was a much stronger predictor of cardiovascular disease than sodium or potassium alone.

“There isn’t as much focus on potassium, but potassium seems to be effective in lowering blood pressure and the combination of a higher intake of potassium and lower consumption of sodium seems to be more effective than either on its own in reducing the risk of cardiovascular disease,” said Dr. Paul Whelton, senior author of the study in the January 2009 issue of the Archives of Internal Medicine. Whelton is an epidemiologist and president and CEO of Loyola University Health System.

Researchers determined average sodium and potassium intake during two phases of a study known as the Trials of Hypertension Prevention. They collected 24 hour urine samples intermittently during an 18 month period in one trial and during a 36 month period in a second trial. The 2,974 study participants initially aged 30 to 54 and with blood pressure readings just under levels considered high, were followed for 10-15 years to see if they would develop cardiovascular disease. Whelton was national chair of the Trials of Hypertension Prevention.

Those with the highest sodium levels in their urine were 20 percent more likely to suffer strokes, heart attacks or other forms of cardiovascular disease compared with their counterparts with the lowest sodium levels. However this link was not strong enough to be considered statistically significant.

Read the full Article.


Wednesday, January 7th, 2009

An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered to patients at NewYork-Presbyterian Hospital/Columbia University Medical Center. Known as the PARTNER (Placement of AoRTic traNscathetER valves) trial, this Phase 3 multicenter study is being led by national co-principal investigators Dr. Martin Leon and Dr. Craig Smith and is focused on the treatment of patients who are at high risk or not suitable for open-heart valve replacement surgery.

The Edwards SAPIEN transcatheter heart valve, made of bovine pericardial tissue leaflets hand-sewn onto a metal frame, is implanted via one of two catheter-based methods — either navigated to the heart from the femoral artery in the patient’s leg, or through a small incision between the ribs and into the left ventricle. It is then positioned inside the patient’s existing valve, using a balloon to deploy the frame, which holds the artificial valve in place. Both procedures are performed on a beating heart, without the need for cardiopulmonary bypass and its associated risks.

“This breakthrough technology could save the lives of thousands of patients with heart valve disease who have no other therapeutic options,” says Dr. Leon, the study’s national co-principal investigator, associate director of the Cardiovascular Interventional Therapy (CIVT) Program at NewYork-Presbyterian Hospital and Columbia University Medical Center, and professor of medicine at Columbia University College of Physicians and Surgeons.

Read more in our News Page.